Two New Drugs Could Help with Migraine Pain: Study

Two New Drugs Could Help with Migraine Pain: Study

Two new drugs that offer relief for migraine have showcased impressive results in recently conducted studies. More than a billion people worldwide suffer from varying degree of migraine pains. Current migraine treatments involve use of drugs primarily meant for high blood pressure, depression and epilepsy. The new drugs work by using special antibodies to suppress a system in the brain that deals with pain.

Detailed results of the studies conducted on people suffering from migraine have been published in the New England Journal of Medicine. The research teams noticed that the drugs work on reducing headache, nausea and other effects caused by migraine. There are more than 40 million people in the United States suffering from migraine.

The study team enrolled 700 people suffering frequently from migraine pain. With long-acting, once in a month shot of new medication, nearly half of patients suffered lesser migraine attacks. Study subjects were given monthly shots for three months.

Peter Goadsby, professor of neurology at King's College in London informed, "They offer the first migraine treatment that's actually aimed at the disorder. We give patients a choice between a beta blocker where they'll feel tired, or we tell them they can go on an antidepressant, which will make them sleepy and put on weight." Professor Goadsby was involved with one of the research project published in NEJM.

Amgen and Novartis are working on developing new class of treatment for migraine pain. Eli Lilly and Co. and Alder Biopharmaceuticals also are testing similar drugs.

As per reports, the U.S. FDA will be reviewing results of both the drugs in early 2018. If the drugs receive FDA approval, they could be launched by second half of year 2018.